Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - VNUS Medical Technologies makes appointment:

This article was originally published in Clinica

Executive Summary

VNUS Medical Technologies (San Jose, California), a company that specialises in devices for minimally-invasive treatment of venous disease, has appointed Kirti Kamdar as senior vice-president of R&D. Mr Kamdar has worked in medical device R&D for 20 years and joins the company from Cardiac Dimensions (Kirkland, Washington), where he was the firm's senior vice-president. He has served in several senior management roles within the industry including at Vascular Architects, Somnus Medical Technologies and Mallinckrodt Medical.

You may also be interested in...



Coronavirus Update: UK Calls For COVID-19 Patients To Join Trials

Australia Relaxes Competition Rules To Facilitate Coronavirus Response

Australia’s competition regulator, the ACCC, has granted a conditional dispensation to allow generics industry association the GBMA and brand body Medicines Australia to work together to help address the coronavirus pandemic by sharing information on stock, inventory, manufacturing and the supply chain. However, tender pricing will not be among the subjects discussed.

Interview: Izana Tests GM-CSF Drug For Coronavirus

The UK biotech's CEO tells Scrip that Izana's objective is to treat rapidly deteriorating COVID-19 patients before ICU admission and prior to ventilation.

Topics

UsernamePublicRestriction

Register

MT050366

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel